JFS Wealth Advisors’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-37
Closed -$500 2004
2024
Q2
$500 Sell
37
-1
-3% -$20 ﹤0.01% 1805
2024
Q1
$1.05K Buy
38
+1
+3% +$22 ﹤0.01% 1646
2023
Q4
$713 Sell
37
-17
-31% -$308 ﹤0.01% 1726
2023
Q3
$873 Buy
54
+13
+32% +$231 ﹤0.01% 1627
2023
Q2
$781 Buy
41
+35
+583% +$624 ﹤0.01% 1669
2023
Q1
$88 Sell
6
-32
-84% -$573 ﹤0.01% 1897
2022
Q4
$742 Buy
+38
New +$741 ﹤0.01% 1666
2022
Q3
Sell
-46
Closed -$1K 1868
2022
Q2
$1K Buy
46
+2
+5% +$72 ﹤0.01% 1603
2022
Q1
$2K Buy
44
+28
+175% +$1.2K ﹤0.01% 1467
2021
Q4
$1K Buy
+16
New +$627 ﹤0.01% 1491

Other funds holding ACH

JFS Wealth Advisors's ACH Position: Q3 2024 in Review

JFS Wealth Advisors sold out of Accendra Health (ACH) in Q3 2024, closing a stake of 37 shares — an estimated $500 sold.

JFS Wealth Advisors first reported a position in ACH in Q4 2021 and held it in 10 quarters. The position peaked at $2K in Q1 2022. 214 funds tracked by Wall St. Rank hold ACH as of Q3 2024.

  • JFS Wealth Advisors reported no remaining Accendra Health position as of Q3 2024 after selling out during the quarter.
  • JFS Wealth Advisors sold 37 Accendra Health shares in Q3 2024, an estimated $500.
  • JFS Wealth Advisors first reported a position in Accendra Health in Q4 2021 and held it in 10 quarters.
  • JFS Wealth Advisors's Accendra Health position peaked at $2K in Q1 2022.
  • 214 funds tracked by Wall St. Rank held Accendra Health as of Q3 2024.

Based on JFS Wealth Advisors's 13F filing for Q3 2024, filed 25 Oct 2024.